Article by Dr David Bunton (co-authored) in the European Pharmaceutical Review, Autumn 2017
27 September 2017
REPROCELL Europe Ltd’s CEO, Dr David Bunton, has co-authored an article titled New Strategy that has been published in the European Pharmaceutical Review, Autumn 2017. The article is in the EPR’s section, Applied Research, Development and P...
Nicola Sturgeon: interview at the official opening of REPROCELL’s Centre for Predictive Drug Discovery (YouTube video)
10 August 2017
This following video is from Nicola Sturgeon, First Minister of Scotland's YouTube channel: “First Minister Nicola Sturgeon officially opened the new European headquarters of a life sciences company which is set to generate 15 new jobs and ...
Press Release: Nicola Sturgeon, First Minister of Scotland, opens REPROCELL European Headquarters in Glasgow
10 August 2017
New headquarters strengthen drug discovery services and translational research, and generate new employment opportunities in Scotland. Press release 10th August 2017. Glasgow, UK. 10th August 2017: REPROCELL Europe Ltd (REPROCELL), a leadin...
REPROCELL and Fox Chase Cancer Center Partner to Open Multi-Site Biosample Repository in India
24 May 2017
Joint Venture Provides Quality Source of Clinically Annotated Tissue Specimens from Vast Indian Population Location: REPROCELL USA Inc. (Beltsville, MD) Business Unit: REPROCELL Discovery Date: May 24, 2017 Announcement (Marketwired) — REPR...
REPROCELL and Fox Chase Cancer Center Form Strategic Alliance to Accelerate Biomarker and Genetic Discovery
13 April 2017
Alliance Provides Wider Access to Oncology Biospecimens to Accelerate Discovery and Translational Studies Location: REPROCELL USA Inc. (Beltsville, MD) Business Unit: REPROCELL Discovery Date: April 13, 2017 Announcement (Marketwired) — REP...
REPROCELL Europe’s CEO Dr David Bunton presented at NC3Rs workshop: Human tissue models for cancer research
03 March 2017
REPROCELL Europe’s CEO, Dr David Bunton presented at the recent NC3Rs meeting on the use of human tissues in cancer research. The conference considered the potential for human tissue models to help reduce clinical drug attrition and provide...
REPROCELL Inc CEO meets with Scottish Cabinet Secretary Fiona Hyslop in Japan
14 February 2017
REPROCELL Inc. (Japan)’s CEO Dr Chikafumi Yokoyama had the honour of meeting with Fiona Hyslop, Cabinet Secretary for Culture, Tourism and External Affairs for the Scottish Government, during her visit to the Scottish Enterprise Tokyo offic...
Scottish Enterprise Association Honours REPROCELL with Annual Awards Nomination
07 February 2017
Scotland’s Life Sciences Dinner was held on 2nd February 2017 at the National Museum of Scotland. The event was attended by CEO and Chairman of REPROCELL Inc, Dr Chikafumi Yokoyama, as well as senior management members of REPROCELL Europe L...
Prof Stefan Przyborski to chair the SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb)
13 January 2017
The SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb) will be chaired by REPROCELL Europe’s chief scientific officer (CSO), Professor Stefan Przyborski. He will also be giving the first lecture in the conference. The SMi Group is a hi...
Notice of formation of contract with Healios K.K. for testing services for regenerative pharmaceutical products
22 November 2016
REPROCELL announces an entrustment contract with Healios K.K. (headquarters: Minato Ward, Tokyo; president and CEO: Tadanao Kagimoto; hereafter, Healios) for sample testing support of human clinical trials conducted by Healios, as well as t...